Enanta Pharmaceuticals

• NCT06917508

  Phase 1, Completed, 24 people, 8 Apr 2025

• NCT05594615

  Phase 1, Completed, 24 people, 26 Oct 2022

• NCT04498741

  Phase 1, Completed, 89 people, 4 Aug 2020

• NCT03783897

  Phase 1, Completed, 43 people, 21 Dec 2018

• NCT03750383

  Phase 1, Completed, 48 people, 23 Nov 2018

• NCT03187496

  Phase 1, Completed, 24 people, 15 Jun 2017

• Nicotinamide Riboside for Patients With Early-Stage Parkinson Disease: The NOPARK Randomized Clinical Trial

  Fees or honoraria, 8 Oct 2026

• Comparing frailty index distribution, mortality and frailty dynamics across multiple countries: applying the 'zero-state' principle to harmonised ageing data

  Patents or royalties, 3 Aug 2026

Sources: pubmed.ncbi.nlm.nih.gov